Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes
3-oxazolidin-4-yl]-7-methoxy-6-methyl-8-(prop-2-en-1-yloxy)-1
RG-13022 inhibits not only EGF-induced growth but also growth stimulated by insulin
Formula: C36H34Cl2N2O7
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C Inhibitory effects of curcumenol on( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
US$ 22318.08
US$ 15913.73
US$ 29892.80
US$ 19858.25
US$ 8841.51
US$ 43753.43